Stone House Investment Management’s Terns Pharmaceuticals TERN Stock Holding History

Stone House Investment Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41	Closed	-$2.16K	–	1416
2026 Q1	$2.16K	Buy	41 +38	+1,267%	+$1.56K	﹤0.01%	582
2025 Q4	$121	Buy	+3	New	+$69	﹤0.01%	826
2024 Q3	–	Sell	-1,000	Closed	-$6.81K	–	419
2024 Q2	$6.81K	Hold	1,000	–	–	﹤0.01%	252
2024 Q1	$6.56K	Buy	+1,000	New	+$6.53K	﹤0.01%	270

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Stone House Investment Management's TERN Position: Q2 2026 in Review

Stone House Investment Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 41 shares — an estimated $2.16K sold.

Stone House Investment Management first reported a position in TERN in Q1 2024 and held it in 4 quarters. The position peaked at $6.81K in Q2 2024. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Stone House Investment Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Stone House Investment Management sold 41 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.16K.
Stone House Investment Management first reported a position in Terns Pharmaceuticals in Q1 2024 and held it in 4 quarters.
Stone House Investment Management's Terns Pharmaceuticals position peaked at $6.81K in Q2 2024.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.